Revive Therapeutics Ltd (RVVTF)

[Gatorca]

Cw,
I did like this part,The Company plans to complete its initial evaluation of the Study’s data with an independent biostatistician team by the end of June. The Company believes that once it has completed the evaluation of the Study’s data, it could support further discussions with the FDA on potential new clinical studies and allow the opportunity to work with potential domestic and international pharmaceutical partners to determine a suitable regulatory pathway for approval of Bucillamine based on the evaluated Study’s data.

Ps.. expect the data by the end of June . Hopefully..

Pps. We wait some more and more lol :) holding not selling any this low unless I have to....